Results 151 to 160 of about 2,243,245 (285)

Breakthrough Hemolysis in Paroxysmal Nocturnal Hemoglobinuria: Mechanistic Insights and Management Strategies

Transfusion, EarlyView.
Abstract Background Paroxysmal nocturnal hemoglobinuria (PNH) is a clonal hematopoietic stem cell disorder caused by somatic mutations in the PIGA gene, resulting in loss of glycosylphosphatidylinositol (GPI)‐anchored proteins, including the complement regulatory proteins, CD55 and CD59.
Ganesh Raman, Meghana Vivek, Rida Hasan, Siobán Keel, Laura Connelly‐Smith   +4 more
wiley   +1 more source

Knowledge, Attitude, and Practice Regarding Adverse Transfusion Reactions Among Nurses, Physicians, and Transfusion Specialists in China: A Multicenter Cross-Sectional Survey. [PDF]

J Multidiscip Healthc
Hu T, Zhou X, OuYang X, Wang Y, Sun T.
europepmc   +1 more source

Adverse Reactions to Blood Transfusion: Introduction — Historical Overview [PDF]

Anaesthesia and Intensive Care, 1980
openaire   +2 more sources

Artificial intelligence in the identification and prediction of adverse transfusion reactions(ATRs) and implications for clinical management: a systematic review of models and applications. [PDF]

BMC Med Inform Decis Mak
ShojaeiBaghini M, Ghaemi MM, Ahmadipour A.   +2 more
europepmc   +1 more source

Evaluation of an ABO antibody immunoadsorption column for reduction of anti‐A and anti‐B isoagglutinin titers in group O platelet units

Transfusion, EarlyView.
Abstract Background Clinical guidelines recommend transfusing ABO‐identical platelets where possible. However, the short shelf life of platelets (5–7 days) and stock availability mean ABO‐nonidentical platelet transfusions are sometimes unavoidable. Minor ABO‐incompatible platelet transfusions carry a risk of hemolysis due to donor anti‐A/B antibodies,
Melanie J. Robbins, Susan Proffitt, Gillian Eastwood, Sian Huish, Kurt Nilsson, Rebecca Cardigan   +5 more
wiley   +1 more source

Patterns of Adverse Transfusion Reactions in a Tertiary Care Centre of North India: A Step Towards Hemovigilance. [PDF]

Indian J Hematol Blood Transfus, 2017
Bassi R, Aggarwal S, Bhardwaj K, Thakur KK.   +3 more
europepmc   +1 more source

Prehospital whole blood transfusion versus component therapy—A scoping review

Transfusion, EarlyView.
Abstract Background Whole blood has gained a foothold over component therapy in civilian emergency care, especially in emergency departments. In a prehospital setting, whole blood might be the logistically easier alternative compared to component therapy. However, most previous studies have been conducted in the emergency room setting.
Laura Muurinen, Timo Jama, Tom Silfvast, Jouni Lauronen   +3 more
wiley   +1 more source

Prophylactic oral calcium–vitamin D3–magnesium supplementation reduced citrate‐related reactions during peripheral blood stem cell collection in healthy donors: A randomized controlled trial

Transfusion, EarlyView.
Abstract Background Citrate‐related reactions remain the most common adverse events during peripheral blood stem cell (PBSC) collection despite routine prophylactic intravenous calcium administration. We evaluated whether prophylactic oral calcium–vitamin D3–magnesium supplementation reduces citrate‐related reactions in healthy PBSC donors.
Keiko Fujii, Toshiharu Mitsuhashi, Hiroko Sainoki, Yuuka Tanaka, Joji Shimono, Hiroyuki Murakami, Fumio Otsuka, Yoshinobu Maeda, Nobuharu Fujii   +8 more
wiley   +1 more source

UNDERREPORTING IN REPORTING SYSTEM FOR ADVERSE TRANSFUSION REACTIONS

Japanese Journal of Transfusion and Cell Therapy, 2015
Noriaki Iwao, Hidefumi Kato, Chikako Odaka, Shigeru Takamoto, Kimitaka Sagawa, Yasuhiko Fujii, Yuji Yonemura, Asashi Tanaka, Hitoshi Okazaki, Yoshiaki Okada, Yasushi Ohkusa, Hisako Nomura, Akio Matsushita, Junichi Kitazawa, Hiroshi Mori, Hitoshi Yasoshima, Kazu Okuma, Kazunari Yamaguchi, Akimichi Ohsaka, Isao Hamaguchi   +19 more
openaire   +2 more sources

Development of a systematic drug screening method for cord blood donation for transfusion to extremely preterm neonates

Transfusion, EarlyView.
Abstract Background Cord blood‐derived red blood cell transfusions (CB‐RBCs) are being developed for extremely preterm neonates to preserve physiological fetal hemoglobin levels. We assessed how standard blood donor medication screening could be adapted for this novel donor population.
Jip H. van Daelen, Elise M. A. Slob, Elise J. Huisman, Irwin K. M. Reiss, Enrico Lopriore, Alex Eggink, Anna L. M. J. van der Knijff ‐ van Dortmont, Thomas R. L. Klei, Masja de Haas, Asghar Zeinali Lathori, Zahraa Hasan, Pauline M. Snijder, Robert B. Flint   +12 more
wiley   +1 more source